Cargando…

Type 2 Diabetes Mellitus: A Pathophysiologic Perspective

Type 2 Diabetes Mellitus (T2DM) is characterized by chronically elevated blood glucose (hyperglycemia) and elevated blood insulin (hyperinsulinemia). When the blood glucose concentration is 100 milligrams/deciliter the bloodstream of an average adult contains about 5–10 grams of glucose. Carbohydrat...

Descripción completa

Detalles Bibliográficos
Autor principal: Westman, Eric C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384107/
https://www.ncbi.nlm.nih.gov/pubmed/34447776
http://dx.doi.org/10.3389/fnut.2021.707371
_version_ 1783741852773515264
author Westman, Eric C.
author_facet Westman, Eric C.
author_sort Westman, Eric C.
collection PubMed
description Type 2 Diabetes Mellitus (T2DM) is characterized by chronically elevated blood glucose (hyperglycemia) and elevated blood insulin (hyperinsulinemia). When the blood glucose concentration is 100 milligrams/deciliter the bloodstream of an average adult contains about 5–10 grams of glucose. Carbohydrate-restricted diets have been used effectively to treat obesity and T2DM for over 100 years, and their effectiveness may simply be due to lowering the dietary contribution to glucose and insulin levels, which then leads to improvements in hyperglycemia and hyperinsulinemia. Treatments for T2DM that lead to improvements in glycemic control and reductions in blood insulin levels are sensible based on this pathophysiologic perspective. In this article, a pathophysiological argument for using carbohydrate restriction to treat T2DM will be made.
format Online
Article
Text
id pubmed-8384107
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83841072021-08-25 Type 2 Diabetes Mellitus: A Pathophysiologic Perspective Westman, Eric C. Front Nutr Nutrition Type 2 Diabetes Mellitus (T2DM) is characterized by chronically elevated blood glucose (hyperglycemia) and elevated blood insulin (hyperinsulinemia). When the blood glucose concentration is 100 milligrams/deciliter the bloodstream of an average adult contains about 5–10 grams of glucose. Carbohydrate-restricted diets have been used effectively to treat obesity and T2DM for over 100 years, and their effectiveness may simply be due to lowering the dietary contribution to glucose and insulin levels, which then leads to improvements in hyperglycemia and hyperinsulinemia. Treatments for T2DM that lead to improvements in glycemic control and reductions in blood insulin levels are sensible based on this pathophysiologic perspective. In this article, a pathophysiological argument for using carbohydrate restriction to treat T2DM will be made. Frontiers Media S.A. 2021-08-10 /pmc/articles/PMC8384107/ /pubmed/34447776 http://dx.doi.org/10.3389/fnut.2021.707371 Text en Copyright © 2021 Westman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Westman, Eric C.
Type 2 Diabetes Mellitus: A Pathophysiologic Perspective
title Type 2 Diabetes Mellitus: A Pathophysiologic Perspective
title_full Type 2 Diabetes Mellitus: A Pathophysiologic Perspective
title_fullStr Type 2 Diabetes Mellitus: A Pathophysiologic Perspective
title_full_unstemmed Type 2 Diabetes Mellitus: A Pathophysiologic Perspective
title_short Type 2 Diabetes Mellitus: A Pathophysiologic Perspective
title_sort type 2 diabetes mellitus: a pathophysiologic perspective
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384107/
https://www.ncbi.nlm.nih.gov/pubmed/34447776
http://dx.doi.org/10.3389/fnut.2021.707371
work_keys_str_mv AT westmanericc type2diabetesmellitusapathophysiologicperspective